US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 3.1000
  • +0.1816+6.22%
Close Apr 26 16:00 ET
3.63MMarket Cap-239P/E (TTM)

Virpax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Virpax Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-3.87

-49.42%
Analyst Rating

Buy

Mar 4, 2024

Virpax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

Virpax Pharmaceuticals Earnings Reports

  • Virpax Pharmaceuticals | 10-K: Annual report

    Mar 26 08:19 ET

  • Virpax Pharmaceuticals: Q3 2023 Earnings Report

    Dec 7, 2023 08:50 ET

  • Virpax Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 09:15 ET

  • Virpax Pharmaceuticals | 10-Q: Q1 2023 Earnings Report

    May 12, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 4, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg